Cisbio Bioassays Marks Next Step in Development of Tag-lite™ GPCR Investigation Platform
Want to listen to this article for FREE?
Complete the form below to unlock access to ALL audio articles.
Read time: Less than a minute
Cisbio Bioassays, a member of IBA group and global developer of HTRF® (Homogeneous Time-Resolved Fluorescence) technology and services
used in assay development and drug screening, today announced that it has extended its Tag-lite™ cell surface receptor platform with the introduction of a comprehensive catalogue of ligands and plasmids.
The new catalogue marks the next step in the company’s development of a complete array of tools for G-Protein Coupled Receptor (GPCR) investigation and, more specifically, of Tag-lite, its homogeneous and non-radioactive
alternative for the study of cell surface receptor dimerization and ligand binding.
used in assay development and drug screening, today announced that it has extended its Tag-lite™ cell surface receptor platform with the introduction of a comprehensive catalogue of ligands and plasmids.
The new catalogue marks the next step in the company’s development of a complete array of tools for G-Protein Coupled Receptor (GPCR) investigation and, more specifically, of Tag-lite, its homogeneous and non-radioactive
alternative for the study of cell surface receptor dimerization and ligand binding.
